Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs

Dependence on opioids and the number of opioid overdose deaths are serious and escalating public health problems, but medication-assisted treatments for opioid addiction remain inadequate for many patients. Glucagon-like pepide-1 (GLP-1) is a gut hormone and neuropeptide with actions in peripheral t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bornebusch, Annika Billefeld, Fink-Jensen, Anders, Wörtwein, Gitta, Seeley, Randy J., Thomsen, Morgane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2019
Materias:
Negative Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498420/
https://www.ncbi.nlm.nih.gov/pubmed/31058214
http://dx.doi.org/10.1523/ENEURO.0443-18.2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498420/
https://www.ncbi.nlm.nih.gov/pubmed/31058214
http://dx.doi.org/10.1523/ENEURO.0443-18.2019

Ejemplares similares